Mayo Clinic: Gene expression profiling not quite perfected in predicting lung cancer prognosis

17th Nov 2006, 06:52 GMT

While there have been significant advances in the use of gene expression profiling to assess a cancer prognosis, a Mayo Clinic review and analysis of existing lung cancer studies shows that this technology has not yet surpassed the accuracy of conventional methods used to assess survival in lung cancer patients.